Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
2007-7-30
pubmed:abstractText
The first choice treatment for vitiligo vulgaris is narrow-band UVB (NB-UVB), but no satisfactory treatment exists.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0926-9959
pubmed:author
pubmed:issnType
Print
pubmed:volume
21
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
942-50
pubmed:meshHeading
pubmed-meshheading:17659004-Administration, Oral, pubmed-meshheading:17659004-Adult, pubmed-meshheading:17659004-Aged, pubmed-meshheading:17659004-Combined Modality Therapy, pubmed-meshheading:17659004-Double-Blind Method, pubmed-meshheading:17659004-Female, pubmed-meshheading:17659004-Humans, pubmed-meshheading:17659004-Male, pubmed-meshheading:17659004-Middle Aged, pubmed-meshheading:17659004-Phytotherapy, pubmed-meshheading:17659004-Plant Extracts, pubmed-meshheading:17659004-Polypodium, pubmed-meshheading:17659004-Prospective Studies, pubmed-meshheading:17659004-Severity of Illness Index, pubmed-meshheading:17659004-Skin Pigmentation, pubmed-meshheading:17659004-Statistics, Nonparametric, pubmed-meshheading:17659004-Treatment Outcome, pubmed-meshheading:17659004-Ultraviolet Therapy, pubmed-meshheading:17659004-Vitiligo
pubmed:year
2007
pubmed:articleTitle
Treatment of vitiligo vulgaris with narrow-band UVB and oral Polypodium leucotomos extract: a randomized double-blind placebo-controlled study.
pubmed:affiliation
Netherlands Institute for Pigment Disorders, Department of Dermatology, Academic Medical Center, 1100 DD Amsterdam, The Netherlands. m.a.middelkamphup@amc.uva.nl
pubmed:publicationType
Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't